ALS
Grapevine, June 24, 2026: Reliving the nightmare - opinion
Movers and shakers in Israeli society.
'Nothing is inevitable': Veteran journalist Oren Nahari on Israel, history, and battle with ALS
Oren Nahari revealed he has ALS: This is the drug given in Israel as compassionate treatment
'Grey's Anatomy,' 'Euphoria' actor Eric Dane dies at 53 to ALS
Ady Barkan, healthcare activist who fought Lou Gehrig’s disease, dies at 39
In 2017, as a new father given just years to live, he literally threw his body into action, protesting Republican initiatives at the U.S. Capitol, crisscrossing the country and raising millions.
Tiny sensors allows this ALS patient to communicate
At 62 words per minute, with a vocabulary of 125,000, brain sensor implants helped interpret a woman's intended speech and printed it on screen.
Israeli chain launches campaign for Global ALS Awareness Day
In honor of the Global ALS Awareness Day, Israeli chain Noi Sheda and IsrA.L.S. Association is partnering up for a new campaign.
Elite soccer players 1.5 times more likely to develop Alzheimer's -study
A new study aimed to determine the risk of neurodegenerative disease among male players in the top Swedish soccer division Allsvenskan compared to the general population.
New research uncovers method to prevent DNA breakdown, aging - study
The research focuses on a protein called SIRT6, which seems to have remarkable properties.
Weizmann Institute researchers discover new Lou Gehrig’s disease neural pathway
The incurable neurological condition, which affects about one in 50,000 people, gradually paralyzes patients, halting the ability to speak, eat, move and even breathe.
Is ALS reversible? -TAU study
Researchers from Tel Aviv University identified the biological mechanism causing nerve destruction in the neurodegenerative disease ALS.
Promising stem-cell based drug for treatment of ALS receives patent
The therapeutic drug is safe for administration and helpful in slowing disease progression, as well as increasing life expectancy and the overall quality of life for ALS patients.
Hillel's Tech Corner: NeuroSense: What ALS patients deserve
NeuroSense Therapeutics is a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Israeli biotech firm's ALS treatment shows safety of use in trials
The objective of this trial was to evaluate the safety of their treatment, with a secondary objective of the trial of estimating its preliminary efficacy.
